CD2 Antibody [Clone BH1]
Purified Mouse Monoclonal Antibody
- 产品详情
- 实验流程
- 背景知识
Application ![]()
| FC |
---|---|
Primary Accession | P06729 |
Reactivity | Human |
Host | Mouse |
Clonality | Monoclonal |
Isotype | IgG2b, kappa |
Clone Names | BH1 |
Calculated MW | 39448 Da |
Gene ID | 914 |
---|---|
Other Names | T-cell surface antigen CD2, Erythrocyte receptor, LFA-2, LFA-3 receptor, Rosette receptor, T-cell surface antigen T11/Leu-5, CD2, CD2, SRBC |
Target/Specificity | Human CD2 protein |
Application Note | Flow Cytometry 2.5ul (0.5ug) per test per one million cells. |
Format | 0.5 ml at 200ug/ml; Conjugated to AF488 |
Storage | Store at 2 to 8°C.Antibody is stable for 24 months. |
Precautions | CD2 Antibody [Clone BH1] is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | CD2 |
---|---|
Synonyms | SRBC |
Function | CD2 interacts with lymphocyte function-associated antigen CD58 (LFA-3) and CD48/BCM1 to mediate adhesion between T-cells and other cell types. CD2 is implicated in the triggering of T-cells, the cytoplasmic domain is implicated in the signaling function. |
Cellular Location | Cell membrane; Single-pass type I membrane protein |
Tissue Location | Expressed in natural killer cells (at protein level). |
For Research Use Only. Not For Use In Diagnostic Procedures.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
CD2 interacts through its amino-terminal domain with the extracellular domain of CD58 (also designated CD2 ligand) to mediate cell adhesion. CD2/CD58 binding can enhance antigen-specific T cell activation. CD2 is a transmembrane glycoprotein that is expressed on peripheral blood T lymphocytes, NK cells and thymocytes. CD58 is a heavily glycosylated protein with a broad tissue distribution in hematopoietic and other cells, including endothelium. Interaction between CD2 and its counter receptor LFA3 (CD58) on opposing cells optimizes immune system recognition, thereby facilitating communication between helper T lymphocytes and antigen-presenting cells, as well as between cytolytic effectors and target cells.
REFERENCES
1. Wang MY et. al. An effective immuno-magnetic method for bone marrow purging in T cell malignancies. Bone Marrow Transplant. 1992;9(5):319-23.

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。
如有疑问,联系:0512-88856768 tech-china@abcepta.com.